Krystal Biotech announced the first patient has been dosed in EMERALD-1, its phase 1/2 clinical trial evaluating KB801 for ...

BI 1815368, a potential oral treatment to improve vision in patients with diabetic macular edema, is being investigated in a ...

Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell ...

Alcon’s Voyager is a fully automated, noncontact treatment approach that delivers 120 laser pulses through the limbus of the ...

Senior eye care experts have cautioned Nigerians against the use of breast milk and cow urine as remedies for eye infections ...

The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's blood cancer drug Blenrep, when used in combination with other treatments, may cause eye damage in ...

It is administered intravenously, unlike current treatments, which need injections into the eye. Read more at ...

Treatment with botulinum toxin A appears to improve tear production and stability and relieve symptoms in patients with dry ...

Dheeraj Kumar, one of India’s most prominent actor/directors died earlier today. He was 80 years old, and passed away from ...

LASIK surgery continues to be one of the most popular and effective methods of correcting vision problems caused by ...

PITTSBURGH, July 09, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) announced today that the first patient has been dosed in its Phase 1/2 clinical trial ("EMERALD-1”), ...

Marking a milestone in precision oncology, Concord treats a rare choroidal melanoma case with cutting-edge proton therapy.